Neudle.com: dopaminergic desensitization

Differential
(Click to cross reference)

acetylcholine

acrochordon

acromegaly

activities of daily living

Addison's disease

advances in neurology

adverse drug reaction

alcohol, neurologic complications with

alcoholism

alopecia

alpha methyldopa hydrazine

alpha methyltyrosine

alpha-synuclein

altered states of consciousness, driving with

amyotrophic lateral sclerosis

amyotrophic lateral sclerosis, etiology of

anasarca

anemia, iron deficiency

angiography, cerebral

ankle edema

anticholinergic drugs

anticholinergic drugs, side effects of

anticonvulsants

anxiety

aortic valve, lesion of

aphasia

aphasia, rehabilitation

apomorphine

arrhythmia, cardiac

arterial dissection, aorta, cerebral symptoms with

arteriopathy

ataxia, truncal

attention deficit disorder with hyperactivity

atypical

automobile accidents

autonomic dysfunction

basal ganglia, lesion of

behavioral disorder

benzodiazepine

beta adrenergic blocker

bitemporal visual field defect

brain implant, polymeric

brain transplantation

bromocriptine

bromocriptine, slow release

carpal tunnel syndrome

CAT scan, emission, abnormal

catecholamine

catechol-o-methyltransferase inhibitor

cerebellar pontine angle

cerebellar pontine angle tumor

cerebral ischemia

cerebrospinal fluid

cerebrospinal fluid, abnormal

cerebrospinal fluid, elevated protein of

cerebrospinal fluid, leak

cerebrovascular accident

cerebrovascular accident, women

chest x-ray, abnormal

Chiari Frommel syndrome

chromophobe adenoma, treatment of

chromosomal abnormality

cirrhosis

cisternogram, radionuclide

congestive heart failure

conjunctival injection

constipation

controversies in neurology

coronary artery disease

cough

cranial nerve palsies

degenerative diseases of CNS

dexamethasone suppression test

disability rating scale, neurological

disability, neurological

diurnal variation

domperidone

dopa responsive dystonia

dopamine

dopamine agonist

dopamine agonist withdrawal syndrome

dopamine antagonist

dopamine antagonist, peripheral

dopamine receptor

dopamine receptor, D2

dopaminergic desensitization

dopaminergic dysfunction

dopaminergic neurons

doppler, transcranial

downward gaze, paralysis of

driving

drug induced neurologic disorders

dystonia musculorum deformens

dystonia, face

dystonia, focal

echocardiogram

echocardiogram, transthoracic

edema, pedal

efficacy

electroconvulsive therapy

emergencies, neurologic

epidemiology of neurology

eye movement, disorders of

fine motor function, impaired

flushing

follicle stimulating hormone

gamma amino butyric acid

gastrointestinal bleeding

gaze palsy, horizontal

gaze palsy, vertical

gene

gene mutation

genetic neurologic disorders

Gilles de la Tourette syndrome

glabellar sign

glomus jugulare tumor

goiter

growth hormone

growth hormone deficiency

hair, loss

hallucination

hallucination, auditory

haloperidol

handwriting

headache

headache, drug induced

headache, treatment of

hearing loss

hemidystonia

hepatic encephalopathy

hepatic encephalopathy, treatment of

heralding manifestation

hypotension, systemic

hypothalamus, damage to

hypothermia

hypothyroidism

iatrogenic neurologic disorders

internuclear ophthalmoplegia

intracerebral hemorrhage

L-dopa, controlled release

L-dopa, drug interactions with and side effects of

L-dopa, potentiators of

lergotrile

Lesch-Nyhan syndrome

level of consciousness, decreased

Lewy body

Lewy body disease, diffuse

locus ceruleus, lesion of

medication withdrawal

microsurgery, transsphenoidal

migraine

migraine, menses

migraine, treatment of

misdiagnosis

mitochondrial disease

mitral valve lesion

mitral valve regurgitation

molecular genetics

monoamine oxidase inhibitors

movement disorder, drug induced

movement disorder, extrapyramidal

movement disorder, extrapyramidal-treatment of

movement disorder, treatment of

MPTP

MRI

MRI, abnormal

MRI, contrast enhanced

neoplasm, hormone producing

neoplasm, hormone producing, ectopic

neoplasm, metastatic to CNS

neoplasm, metastatic to CNS-treatment of

neoplasm, pituitary

neoplasm, pituitary, incidental

neoplasm, pituitary, treatment of

neoplasm, primary of CNS-metastasizing to subarachnoid space

neoplasm, primary of CNS-treatment of

neurochemistry

neuroendocrinology

neuroleptic

neuroleptic malignant syndrome

neuroleptic, atypical

neurologic complications of, surgery

neurologic disease, diagnoses of

neurologic signs

neurologic symptoms

neurologic testing

neuronal degeneration

neurons

neuropathology

neuropathology, brain

neuropathy

neuroprotective agents

neurotoxic

neurotransmitter

nigrostriatal pathway

norepinephrine

obsessive-compulsive disorder

optic chiasm, herniation

oral contraceptives

oral contraceptives, neurologic complications with

orthostatic hypotension

Parkinson disease, dementia with

Parkinson disease, diagnosis

Parkinson disease, differential diagnosis of

Parkinson disease, driving with

Parkinson disease, dystonia with

Parkinson disease, early symptoms

Parkinson disease, etiology of

Parkinson disease, familial

Parkinson disease, fluctuations in

Parkinson disease, freezing phenomena in

Parkinson disease, nonmotor problems of

Parkinson disease, on-off phenomena in

Parkinson disease, pathogenesis of

Parkinson disease, prognosis of

Parkinson disease, progression

Parkinson disease, sensory symptoms in

Parkinson disease, surgical treatment of

Parkinson disease, transient

Parkinson disease, treatment of

parsidol

pathologic gambling

pathology

patient information and support

PHNO, enteral infusion, continuous

pituitary, adenoma, giant

pituitary, enlargement

pituitary, hormones of

pituitary, lesion of

pituitary, microadenoma

polyps, gastrointestinal tract

polysomnogram

postpartum

postpartum cerebral angiopathy

practice guidelines

pramipexole

pramipexole, extended release

pregabalin

pregnancy, neurologic complications in

PRKN gene

procyclidine

prognosis

progressive supranuclear palsy

psychiatric problems in neurologic disorders

psychological testing

psychological testing, neurologic problems

radiation therapy, CNS treatment and complications with

radiation therapy, stereotactic

radioimmunoassay

radiotracer imaging

raphe nuclei

reserpine and reserpine like drugs

respiratory failure

restless arms syndrome

restless genital syndrome

restless leg syndrome

retroperitoneal fibrosis

risk-benefit assessment

ritalin

ropinirole

ropinirole, prolonged release

rotigotine

safety

seizure

sella turcica, enlargement of

sensorineural hearing loss

single photon emission computed tomography

skin, lesions in neurologic disorders

skull x-ray

skull x-ray, abnormal

sleep

sleep apnea

sleep pathology and physiology

smell

Smell Identification Test

somatostatin analogue

stem cell transplantation

stereotyped behavior

stereotyped behavior, drug induced

stereotypy

stimulation, deep brain

striatum, lesion of

subclavian steal syndrome, causes of

substantia nigra

subthalamic nucleus

subthalamic nucleus deep brain stimulation

tardive dyskinesia, treatment of

testicular atrophy

testosterone, serum

testosterone, serum, low

transdermal medication

trauma

treatment of neurologic disorder

tremor

tremor, resting

tremor, thalamic stimulation for suppression of

tricuspid valve, lesion of

tricyclic antidepressant

trismus

twins

undiagnosed

Unified Parkinson Rating Scale

visual acuity, decreased

Showing articles 50 to 100 of 236 << Previous Next >>

Parenteral Metoclopramide for Acute Migraine: Meta-Analysis of Randomised Controlled Trials
BMJ 329:1369-1372, Colman,I.,et al, 2004

Effective Cabergoline Treatment in Idiopathic Restless Legs Syndrome
Neurol 63:2272-2279, Stiasny-Kolster,K.,et al, 2004

Slowing Parkinson's Disease Progression
Neurol 60:381-389, Ahlskog,J.E., 2003

Initial Agonist Treatment of Parkinson Disease
Neurol 60:390-394, Albin,R.L. &Frey,K.A., 2003

[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003

Restless Legs Syndrome
NEJM 348:2103-2109, Earley,C.J., 2003

Pathological Gambling Associated with Dopamine Agonist Therapy in Parkinson's
Neurol 61:422-423, Driver-Dunckley,E.,et al, 2003

Heart Valvular Disease in Patients with Parkinson's Disease Treated with High-Dose Pergolide
Neurol 61:859-861, VanCamp,G.,et al, 2003

Prolactinoma
NEJM 349:2035-2041, Schlechte,J.A., 2003

Withdrawal of Long-Term Cabergoline Therapy for Tumoral and Nontumoral Hyperprolactinemia
NEJM 349:2023-2033, Colao,A.,et al, 2003

A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's Disease
Arch Neurol 60:1721-1728, The Parkinson Study Group, 2003

Excessive Daytime Sleepiness and Sudden-Onset Sleep in Parkinson Disease
JAMA 287:455-463,509, Hobson,D.E.,et al, 2002

Alopecia Induced by Dopamine Agonists
Neurol 58:829-830, Tabamo,R.E. &Di Rocco,A., 2002

Dopamine Transporter Brain Imaging to Assess the Effects of Pramipexole vs Levodopa on Parkinson Disease Progression
JAMA 287:1653-1661, Parkinson Study Group, 2002

SUNCT Syndrome in Two Patient with Prolactinomas and Bromocriptine-Induced Attacks
Neurol 58:1698-1699, Massiou,H.,et al, 2002

Subclinical Dopaminergic Dysfunction in Asymptomatic Parkinson's Disease Patients' Relatives with a Decreased Sense of Smell
Ann Neurol 50:34-41, Berendse,H.W.,et al, 2001

A randomized,Double-blind,Placebo-Controlled Trial of Subcutaneously Injected Apomorphine for Parkinsonian Off-State Events
Arch Neurol 58:1385-1392, Dewey,R.B.,et al, 2001

Ten-year Follow-up of Three Different Initial Treatments in De-novo PD
Neurol 57:1687-1694, Lees,A.J.,et al, 2001

Tourette's Syndrome Improvement with Pergolide in a Randomized, Double-Blind, Crossover Trial
Neurol 54:1310-1315, Gilbert,D.L.,et al, 2000

Dopamine Agonists: Their Role in the Treatment of Parkinson's Disease
JNNP 68;685-690, Brooks,D.J., 2000

Clinical Characteristics of Pramipexole-Induced Peripheral Edema
Arch Neurol 57:729-732, Tan,E.K.&Ondo,W., 2000

A Five-Year Study of the Incidence of Dyskinesia in Patients With Early Parkinson's Disease who were Treated with Ropinirole or Levodopa
NEJM 342:1484-1491, Rascol,O.,et al, 2000

Acute Orhtostatic Hypotension When Starting Dopamine Agonists in Parkinson's Disease
Arch Neurol 57:1461-1463, Kujawa,K.,et al, 2000

Pramipexole vs Levodopa as Initial Treatment for Parkinson Disease
JAMA 284:1931-1938,1971, Parkinson Study Group, 2000

Safety of Pramipexole in Patients with Restless Legs Syndrome
Neurol 55:1589-1590, Stiasny,K.,et al, 2000

Restless Legs Syndrome Improved By Pramipecole, A Double-Blind Randomized Trial
Neurol 52:938-943, Montplaisir,J.,et al, 1999

Efficacy, Safety, and Tolerance of the Non-Ergoline Dopamine Agonist Pramipexole in the Treatment of Advanced Parkinson's Disease:A Double Blind, Placebo Controlled, Randomised, Multicentre Study
JNNP 66:436-441, Pinter,M.M.,et al, 1999

Falling Asleep at the Wheel:Motor Vehicle Mishaps in Persons Taking Pramipexole and Ropinirole
Neurol 52:1908-1910, Frucht,S.,et al, 1999

A 3-Year Randomized Trial of Ropinirole and Bromocriptine in Early Parkinson's Disease
Neurol 53:364-370, Korczyn,A.D.,et al, 1999

Subcutaneous Apomorphine in Parkinson's Disease
Effective Yet Underused, BMJ 316:6411998., , 1998

Depression, Palpitations, and Unilateral Pulsatile Tinnitus Due to a Dopamine-Secreting Glomus Jugulare Tumor
Am J Med 104:310-311, Troughton,R.W.,et al, 1998

Management of Pituitary Tumors
Ann Int Med 129:472-483, Shimon,I.&Melmed,S., 1998

Ropinirole for the Treatment of Early Parkinson Disease
Arch Neurol 55:1211-1216, Sethi,K.D.,et al, 1998

Randomized,Double-Blind,Placebo-Controlled Trial of Pergolide in Restless Leg Syndrome
Neurol 51:1599-1602, Earley,C.J.,et al, 1998

Encouraging Initial Response of Restless Legs Syndrome to Pramipexole
Neurol 51:1221-123, Becker,P.M.,et al, 1998

Parkinson's Disease
NEJM 339:1044-1053,1130-1143, Lang,A.E.&Lozano,A.M., 1998

Cabergoline Treatment of Early Parkinson's Disease:First Yr of Trtm Comparison of Cabergoline & Levodopa
Neurol 48:363-368, Rinne,U.K.,et al, 1997

Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997

Safety and Efficacy of Pramipexole in Early Parkinson Disease
Parkinson Study Group, JAMA 278:125-1301997., , 1997

Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997

Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997

Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997

Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997

Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997

Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996

Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996

Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
NEJM 334:1568-1572, 16021996., Ernst,M.,et al, 1996

Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996

Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996

Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996

Showing articles 50 to 100 of 236 << Previous Next >>